Reducing medication-related harm in the NHS remains a high priority in the NHS Patient Safety Strategy, with a particular focus on reducing the estimated 237 million medication errors that occur in England every year, of which 66 million are potentially clinically significant. Whilst this is no new challenge for the NHS, the formation of ICSs provides a new angle and potential vehicle for change. This award seeks to recognise both organisations and systems that have reduced or eliminated drug errors.
Judges are interested in any initiative designed to improve safety in the use of medications. Initiatives could span several areas, including safe packaging and labelling design, safer prescribing methods, improvements in understanding of human-factor error, the use of metrics to drive a reduction in the risk of harm or changes to administration protocols. Judges are particularly keen to see how patient experience has improved as a result and that teams and organisations have worked together to solve a problem.
Entries are accepted from NHS trusts, ICSs and primary care pharmacy teams improving the safe administration of medicines.